article thumbnail

New mRNA vaccine created to prevent and treat C. difficile

Science Daily: Pharmacology News

difficile first-time infections and relapsing infections by inducing a robust immune response, promote clearance of existing C. diff bacteria from the gut, and even overcome deficits in host immunity to protect animals after infection, according to researchers. In animal models, this first mRNA-LNP C.

Vaccine 309
article thumbnail

Discovery of 'new rules of the immune system' could improve treatment of inflammatory diseases, say scientists

Science Daily: Pharmacology News

These cells shut down inflammation and repair the collateral damage to cells caused after our immune system has responded to injury or illness. Current anti-inflammatory drugs used for this purpose suppress the body's whole immune system, making patients more vulnerable to infection.

Treatment 333
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Researchers design gene therapy that can effectively target glioblastoma

Science Daily: Pharmacology News

Immunotherapies, which mobilize the body's immune defenses against a cancer, have not been effective for GBM, in part because the tumor's surrounding environment is largely impenetrable to assaults from the body's immune system.

Therapies 215
article thumbnail

A dial for tuning the immune system: Discovery sheds light on why COVID makes some sicker than others

Science Daily: Pharmacology News

Researchers have discovered a protein variant that serves as a knob for regulating the body's innate immune response. The findings could lead to new therapies for Long COVID, autoimmune disorders, and more.

article thumbnail

Nasal Spray COVID Vaccine Shows Promise in Early Trial

Drugs.com

11, 2023 -- New research points to the potential of a COVID-19 vaccine delivered through the nose. The phase 1 clinical trial showed that the product, administered nasally in two doses, delivered a significant immune response to. WEDNESDAY, Oct.

Vaccine 286
article thumbnail

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

SCIENMAG: Medicine & Health

Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. Credit: Mike […]

article thumbnail

Cancer vaccine shows promise for patients with stage III and IV kidney cancer

Science Daily: Pharmacology News

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.

Vaccine 254